Klaria Pharma Holding AB (publ.) (FRA:6FN)
Germany flag Germany · Delayed Price · Currency is EUR
0.0648
-0.0016 (-2.41%)
Feb 20, 2026, 4:00 PM EST

FRA:6FN Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-38.89-47.75-35.78-63.77-53.53
Depreciation & Amortization
11.2211.2211.0411.0310.97
Asset Writedown & Restructuring Costs
-4.82---
Other Operating Activities
4.6716.513.99-0.1213.28
Change in Accounts Receivable
-0.9720.77-2.53-0.56
Change in Other Net Operating Assets
-12.042.33-9.075.665.05
Operating Cash Flow
-35.04-11.91-9.06-49.73-24.8
Capital Expenditures
----0.04-
Investing Cash Flow
----0.04-
Long-Term Debt Issued
9.9212.652-20.05
Long-Term Debt Repaid
-6.93-1.36-24.83-0.68-1.05
Net Debt Issued (Repaid)
2.9911.29-22.83-0.6819
Issuance of Common Stock
31.8-16.3741.730.04
Other Financing Activities
--0.02---
Financing Cash Flow
34.7811.27-6.4641.0619.04
Foreign Exchange Rate Adjustments
--0.010-0.02-0
Net Cash Flow
-0.26-0.65-15.51-8.73-5.76
Free Cash Flow
-35.04-11.91-9.06-49.77-24.8
Free Cash Flow Margin
-389.95%-529.67%-107.14%-848.18%-405.71%
Free Cash Flow Per Share
-0.18-0.09-0.09-0.86-0.48
Cash Interest Paid
-0.030.028.693.44
Cash Income Tax Paid
0.06-0.05-0.020.11-0.01
Levered Free Cash Flow
1.60.06-4.75-41.38-37.57
Unlevered Free Cash Flow
10.1410.3-2.46-36.49-35.59
Change in Working Capital
-12.043.311.73.134.49
Source: S&P Global Market Intelligence. Standard template. Financial Sources.